1. Case report {#sec1}
==============

A 25-year-old female with systemic lupus erythematosus requiring multiple immunosuppressive agents presented with a 3-day history of blurred vision in the left eye. Upon initial examination, she was admitted for treatment of disseminated *Nocardia* with central nervous system involvement. Visual acuity (VA) was 20/30 in the right eye and count fingers at 1 foot in the left eye. Examination of the right eye was unremarkable. Slit lamp examination of the left eye revealed 2 + cell in the anterior chamber and vitreous. Fundoscopy of the left eye showed a serous macular detachment with associated subretinal abscess ([Fig. 1](#fig1){ref-type="fig"}A). Blood cultures speciated *Nocardia farcinica* highly susceptible to amikacin. Vitreous tap and injection of amikacin (0.4mg/0.1 ml) was performed (left eye) for presumed endogenous *Nocardia* subretinal abscess; the patient received injections every 3 days while continuing systemic antibiotic therapy with sulfamethoxazole/trimethoprim and imipenem. By day 11, VA in the left eye improved to 20/60 with resolution of the serous detachment and a remarkable decrease in size of the subretinal abscess ([Fig. 1](#fig1){ref-type="fig"}B). Decision was made to stop intravitreal treatment based on clinical improvement. Eight weeks later, the left eye VA improved further to 20/40. Vitreous culture showed no growth.Fig. 1Fundus photograph of the left eye demonstrating serous macular detachment, creamy-white subretinal abscess with a layered pseudohypopyon, and intraretinal hemorrhages (A). Following frequent intravitreal amikacin treatment, there was resolution of the serous detachment with residual subretinal deposits (B), correlating to hyper-reflective lesions (arrowheads) on optical coherence tomography scans (C, scan location correlates to green line; D, scan through fovea). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 1

2. Discussion {#sec2}
=============

*Nocardia* is a gram positive, aerobic bacteria known to cause devastating infections in immunocompromised patients. Subretinal abscess is a rare complication of disseminated nocardiosis with typically poor visual outcomes.[@bib1] Some authors have advocated for early surgical intervention and aspiration of the subretinal abscess.[@bib2] Others have recommended intravitreal injection of amikacin, however there is minimal guidance on the frequency of injections.[@bib1] *Nocardia* species are frequently resistant to many intravitreal antibiotics, but are usually sensitive to amikacin. While uncommon, macular ischemia following intravitreal amikacin is a serious risk to consider with individualized discussions.[@bib3] We felt the potentially devastating vision loss from a macula involving subretinal infection outweighed the risk of ischemia.

3. Conclusions {#sec3}
==============

Our patient had severely reduced vision in the setting of a large submacular abscess. We performed four biweekly injections of intravitreal amikacin, resulting in marked resolution of the abscess and significant improvement in visual acuity. We present a positive clinical response of a patient with a submacular *Nocardia* abscess and suggest that early, frequent intravitreal injections along with systemic antibiotic therapy may support a favorable outcome.
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